Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a commercial biotech company, today announced that its Board of Directors has authorized an intent ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Hot Corp. News Management Comments Spinoffs Trading Halts

Ironwood Pharma (IRWD) Plans to Separate Could Unlock Value of Linzess Profit Stream - BTIGMay 1, 2018 1:48 PM Ironwood Pharma (IRWD) to Resume Trading at 8:30 am ETMay 1, 2018 8:20 AM Ironwood Pharmaceuticals Announces Intent to Separate Soluble Guanylate Cyclase (sGC) Business from Commercial and Gastrointestinal BusinessMay 1, 2018 7:58 AM Ironwood Pharma (IRWD) Misses Q1 EPS by 4cMay 1, 2018 7:56 AM Ironwood Pharmaceuticals Provides First Quarter 2018 Investor UpdateMay 1, 2018 7:55 AM Ironwood Pharma (IRWD) Halted, News PendingMay 1, 2018 7:50 AM